This week's View explores two trials on percutaneous mitral valve repair, MITRA-FR (Percutaneous Repair With the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation) and COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation), and a review letter on elevation of cardiac troponins after endurance running competitions.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, ESC Congress, ESC18, TCT18, Transcatheter Cardiovascular Therapeutics, Adrenergic beta-Antagonists, Athletes, Cardiac Surgical Procedures, Cardiomyopathies, Coronary Artery Bypass, Echocardiography, Exercise, Geriatrics, Heart-Assist Devices, Heart Failure, Heart Transplantation, Heart Valve Diseases, Mitral Valve Insufficiency, Myocardial Infarction, Myocardial Ischemia, Natriuretic Peptide, Brain, Percutaneous Coronary Intervention, Physical Endurance, Primary Prevention, Pulmonary Disease, Chronic Obstructive, Troponin, Stroke, Stroke Volume, Thoracic Surgery, Coronary Angiography, Diagnostic Imaging, Sports

< Back to Listings